Utility of serum complement factors C3 and C4 as biomarkers during therapeutic management of giant cell arteritis.
Edoardo ConticiniBernhard HellmichBruno FredianiElena CsernokChristian LöfflerPublished in: Scandinavian journal of rheumatology (2022)
C3 and C4 do not seem useful in the diagnosis of GCA, as normal values do not rule out active vasculitis. However, C3 and C4 correlate with disease activity. As the low C4 levels found in TCZ-treated patients are not correlated with CRP, C4 should be evaluated as a potential biomarker of disease activity and treatment response.